ConductScience.org, home

Trial · NCT05523297

Results by group180

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Patients Requiring Additional Hemostatic InterventionOctaplexEffective166Participants
Number of Patients Requiring Additional Hemostatic InterventionFrozen PlasmaEffective125Participants
Number of Patients Requiring Additional Hemostatic InterventionOctaplexIneffective47Participants
Number of Patients Requiring Additional Hemostatic InterventionFrozen PlasmaIneffective82Participants
Comparison of Global Hemostatic Response Based on Requirement of Additional Hemostatic Intervention and Decreased Hemoglobin LevelsOctaplexNegative56Participants
Comparison of Global Hemostatic Response Based on Requirement of Additional Hemostatic Intervention and Decreased Hemoglobin LevelsFrozen PlasmaNegative83Participants
Comparison of Global Hemostatic Response Based on Requirement of Additional Hemostatic Intervention and Decreased Hemoglobin LevelsOctaplexPositive157Participants
Comparison of Global Hemostatic Response Based on Requirement of Additional Hemostatic Intervention and Decreased Hemoglobin LevelsFrozen PlasmaPositive122Participants
Compare the Amount of Chest Tube Drainage Between the Octaplex and FP Groups.Octaplex12 hours after chest closure471.20Standard Deviation 358.32Milliliters (mL)
Compare the Amount of Chest Tube Drainage Between the Octaplex and FP Groups.Frozen Plasma12 hours after chest closure641.90Standard Deviation 465.17Milliliters (mL)
Compare the Amount of Chest Tube Drainage Between the Octaplex and FP Groups.Octaplex24 hours after chest closure690.90Standard Deviation 465.62Milliliters (mL)
Compare the Amount of Chest Tube Drainage Between the Octaplex and FP Groups.Frozen Plasma24 hours after chest closure922.90Standard Deviation 631.90Milliliters (mL)
Compare the Incidence of Severe to Massive Bleeding Between the Octaplex and FP Groups Using a Modification of the Universal Definition of Perioperative Bleeding (UDPB).OctaplexWithin 24 hours after IMP start / No183Participants
Compare the Incidence of Severe to Massive Bleeding Between the Octaplex and FP Groups Using a Modification of the Universal Definition of Perioperative Bleeding (UDPB).Frozen PlasmaWithin 24 hours after IMP start / No136Participants
Compare the Incidence of Severe to Massive Bleeding Between the Octaplex and FP Groups Using a Modification of the Universal Definition of Perioperative Bleeding (UDPB).OctaplexWithin 24 hours after IMP start / Yes30Participants
Compare the Incidence of Severe to Massive Bleeding Between the Octaplex and FP Groups Using a Modification of the Universal Definition of Perioperative Bleeding (UDPB).Frozen PlasmaWithin 24 hours after IMP start / Yes71Participants
Compare the Incidence of Severe to Massive Bleeding Between the Octaplex and FP Groups Using a Modification of the Universal Definition of Perioperative Bleeding (UDPB).OctaplexWithin 24 hours after surgery start / No176Participants
Compare the Incidence of Severe to Massive Bleeding Between the Octaplex and FP Groups Using a Modification of the Universal Definition of Perioperative Bleeding (UDPB).Frozen PlasmaWithin 24 hours after surgery start / No129Participants
Compare the Incidence of Severe to Massive Bleeding Between the Octaplex and FP Groups Using a Modification of the Universal Definition of Perioperative Bleeding (UDPB).OctaplexWithin 24 hours after surgery start / Yes37Participants
Compare the Incidence of Severe to Massive Bleeding Between the Octaplex and FP Groups Using a Modification of the Universal Definition of Perioperative Bleeding (UDPB).Frozen PlasmaWithin 24 hours after surgery start / Yes78Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05523297/results